Literature DB >> 1854884

Further evidence for the molecular heterogeneity of chronic myeloid leukemia.

A Hernandez1, L Corral, A Muñiz, C Alaez, E Espinosa, G Martinez, P Hernandez.   

Abstract

Cytogenetic and molecular techniques were performed on samples obtained from 29 patients with chronic myelocytic leukemia (CML); 27 were in the chronic phase and two were in blast crisis. A further five cases were also analyzed, two with atypical CML (aCML), one with chronic neutrophilic leukemia (CNL), and two with juvenile CML (JCML). Most of the cases with typical CML were Philadelphia chromosome (Ph) positive and had a rearrangement within the major breakpoint cluster region (M-bcr). One of these cases was shown to be Ph positive but showed no rearrangement within the M-bcr. Two cases with clinical features typical of CML were Ph negative. One of these showed a rearrangement within the M-bcr, but no rearrangement was demonstrated in the other. Both patients in blast crisis were Ph positive and M-bcr positive. One showed a second Ph. Patients with aCML were Ph negative and had no M-bcr rearrangement. A polymorphism within the M-bcr was found with BglII in one case. No Ph chromosome or M-bcr rearrangement was found in CNL or JCML. These data support the molecular heterogeneity reported in CML.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1854884     DOI: 10.1007/bf01729835

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  30 in total

1.  Trisomy 14 in atypical chronic myeloid leukemia.

Authors:  F Mertens; B Johansson; S Heim; U Kristoffersson; N Mandahl; I Turesson; C Malm; A Othzén; C R Bartram; D Catovsky
Journal:  Leukemia       Date:  1990-02       Impact factor: 11.528

Review 2.  Chronic myelogenous leukaemia: a model for human cancers.

Authors:  R P Gale
Journal:  Baillieres Clin Haematol       Date:  1987-12

Review 3.  Haematological classification of the chronic myeloid leukaemias.

Authors:  P C Shepherd; T S Ganesan; D A Galton
Journal:  Baillieres Clin Haematol       Date:  1987-12

4.  bcr rearrangement in Ph-negative CML.

Authors:  C R Bartram; F Carbonell
Journal:  Cancer Genet Cytogenet       Date:  1986-03-15

Review 5.  Oncogenes and leukemia.

Authors:  A Butturini; R P Gale
Journal:  Leukemia       Date:  1990-02       Impact factor: 11.528

6.  Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction.

Authors:  M S Lee; A LeMaistre; H M Kantarjian; M Talpaz; E J Freireich; J M Trujillo; S A Stass
Journal:  Blood       Date:  1989-06       Impact factor: 22.113

7.  The location of breakpoints within the breakpoint cluster region (bcr) of chromosome 22 in chronic myeloid leukemia.

Authors:  A Eisenberg; R Silver; L Soper; Z Arlin; M Coleman; B Bernhardt; P Benn
Journal:  Leukemia       Date:  1988-10       Impact factor: 11.528

8.  Characterization of the translocation breakpoint in a patient with Philadelphia positive, bcr negative acute lymphoblastic leukaemia.

Authors:  M J van der Feltz; M K Shivji; G Grosveld; L M Wiedemann
Journal:  Oncogene       Date:  1988-08       Impact factor: 9.867

9.  Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

Authors:  J Groffen; J R Stephenson; N Heisterkamp; A de Klein; C R Bartram; G Grosveld
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

10.  C-abl and bcr are rearranged in a Ph1-negative CML patient.

Authors:  C R Bartram; E Kleihauer; A de Klein; G Grosveld; J R Teyssier; N Heisterkamp; J Groffen
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

View more
  1 in total

1.  Biophysical differences between chronic myelogenous leukemic quiescent and proliferating stem/progenitor cells.

Authors:  Nataliia V Guz; Sapan J Patel; Maxim E Dokukin; Bayard Clarkson; Igor Sokolov
Journal:  Nanomedicine       Date:  2016-07-16       Impact factor: 5.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.